UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-QSB [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly period ended August 31, 1996 [ ] TRANSITION REPORT UNDER SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from _____ to _____ COMMISSION FILE NUMBER 0-11408 BIOSENSOR CORPORATION ------------------------------------------------------------------------------ MINNESOTA 41-1427114 (State or other jurisdiction (I.R.S. Employer Identification No.) of incorporation or organization) 13755 First Avenue North, Plymouth, Minnesota 55441 (Address of principal executive offices) (Zip Code) Issuer's telephone number (612) 449-9100 Check whether the Issuer: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the 12 months (or for such shorter period that registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES __X__ NO ____ The number of shares outstanding of the registrant's common stock, $.05 par value, as of October 10, 1996 is 2,823,055. This 10-QSB/A is being submitted to include the Financial Data Schedule omitted from the initial filing. SIGNATURES In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOSENSOR CORPORATION B. Steven Springrose President and Chief Executive Officer Date October ___, 1996